كالفيستا

Chiesi Acquires Calvista Pharmaceuticals for $1.9 Billion

Chiesi Farmaceutici, the Italian pharmaceutical company, has announced its acquisition of the American firm Calvista Pharmaceuticals in a deal valued at approximately <strong>$1.9 billion</strong>. This acquisition marks a significant expansion in Chiesi's portfolio focused on treating rare immune diseases.